서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 9 of 9

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2011-11	Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: A multicenter phase II study Kim, Sun Young; Hong, Yong Sang; Kim, Dae Yong; Kim, Tae Won; Kim, Jee Hyun; Im, Seok Ah; Lee, Keun Seok; Yun, Tak; Jeong, Seung-Yong; Choi, Hyo Seong; Lim, Seok-Byung; Chang, Hee Jin; Jung, Kyung Hae International Journal of Radiation Oncology Biology Physics, Vol.81 No.3, pp.677-683	DOI
2012-06	A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research Oh, Do-Youn; Lee, Keun Wook; Lee, Kyung-Hee; Sohn, Chang-Hak; Park, Young Suk; Zang, Dae Young; Ryoo, Hun-Mo; Song, Hong-Suk; Kim, Jin-Soo; Kang, Hye-Jin; Kim, Bong-Seog; Bang, Yung-Jue Investigational New Drugs, Vol.30 No.3, pp.1164-1174	DOI
2013-12	Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer Lee, K. -W.; Park, S. R.; Oh, D. -Y.; Park, Y. -I.; Khosravan, R.; Lin, X.; Lee, S. -Y.; Roh, E. -J.; Valota, O.; Lechuga, M. J.; Bang, Y. -J. Investigational New Drugs, Vol.31 No.6, pp.1547-1558	DOI
2014-08	Concurrent treatment with capecitabine and radiosurgery in the mouse glioblastoma model 허운학	view file
2014-11	S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial Kim, Seung Tae; Hong, Yong Sang; Lim, Ho Yeong; Lee, Jeeyun; Kim, Tae Won; Kim, Kyu-Pyo; Kim, Sun Young; Baek, Ji Yeon; Kim, Jee Hyun; Lee, Keun-Wook; Chung, Ik-Joo; Cho, Sang-Hee; Lee, Kyung Hee; Shin, Sang Joon; Kang, Hye Jin; Shin, Dong Bok; Lee, Jae Won; Jo, Sook Jung; Park, Young Suk BMC Cancer, 14(1):883	view file DOI
2015-10	Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer Oh, Do-Youn; Doi, Toshihiko; Shirao, Kuniaki; Lee, Keun-Wook; Park, Sook Ryun; Chen, Ying; Yang, Liqiang; Valota, Olga; Bang, Yung-Jue Cancer Research and Treatment, Vol.47 No.4, pp.687-696	DOI
2018-05	Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine Pivot, Xavier; Im, Seock Ah; Guo, Matthew; Marme, Frederik Breast Cancer, Vol.25 No.3, pp.370-374	DOI
2019-01	Randomized Open Labe Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01) Park, In Hae; Im, Seock-Ah; Jung, Kyung Hae; Sohn, Joo Hyuk; Park, Yeon Hee; Lee, Keun Seok; Sim, Sung Hoon; Park, Kyong-Hwa; Kim, Jee Hyun; Nam, Byung Ho; Kim, Hee-Jun; Kim, Tae-Yong; Lee, Kyung-Hun; Kim, Sung-Bae; Ahn, Jin-Hee; Lee, Suee; Ro, Jungsil Cancer Research and Treatment, Vol.51 No.1, pp.43-52	DOI
2019-07	Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study Bang, Yung-Jue; Kang, Yoon-Koo; Catenacci, Daniel V.; Muro, Kei; Fuchs, Charles S.; Geva, Ravit; Hara, Hiroki; Golan, Talia; Garrido, Marcelo; Jalal, Shadia I.; Borg, Christophe; Doi, Toshihiko; Yoon, Harry H.; Savage, Mary J.; Wang, Jiangdian; Dalal, Rita P.; Shah, Sukrut; Wainberg, Zev A.; Chung, Hyun Cheol Gastric Cancer, Vol.22 No.4, pp.828-837	DOI

1